CLOV - NASDAQ
Clover Health Investments, Corp.
$3.96
+8.6%Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
At a Glance
Live SnapshotClover Health Investments, Corp. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.
Debt-to-Equity Ratio
Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Balanced asset mix between current and non-current assets, typical of many stable businesses.
Clover Health Investments, Corp. Balance Sheet
CLOV • NASDAQ
| Clover Health Investments, Corp. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
78.3M | 194.5M | 116.4M | 103.8M | 300M | 92.3M | 0.0 | 75.4M | |
17M | 27M | 119.8M | 231M | 315.3M | 4.4M | 0.0 | 0.0 | |
95.3M | 221.5M | 236.2M | 334.8M | 615.3M | 96.7M | 0.0 | 75.4M | |
158.7M | 92.8M | 86.2M | 167.5M | 109.4M | 84.9M | 0.0 | 0.0 | |
158.7M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 92.8M | 86.2M | 167.5M | 109.4M | 84.9M | 0.0 | 0.0 | |
0.0 | 13.2M | 14.4M | 18.1M | 14.7M | 7.8M | 0.0 | 0.0 | |
53.8M | 15.6M | 91.1M | 104.5M | 13.2M | 299K | 0.0 | 0.0 | |
307.9M | 343.1M | 428M | 625M | 752.5M | 189.8M | 0.0 | 75.4M | |
NON-CURRENT ASSETS | ||||||||
6.4M | 5.3M | 5.1M | 9.8M | 7.7M | 10M | 0.0 | 3.2M | |
0.0 | 0.0 | 0.0 | 11.7M | 0.0 | 0.0 | 0.0 | 0.0 | |
3M | 3M | 3M | 8.3M | 4.2M | 4.2M | 0.0 | 3M | |
3M | 3M | 3M | 20M | 4.2M | 4.2M | 0.0 | 3M | |
187.1M | 201.7M | 121M | 138.1M | 175.9M | 54.4M | 0.0 | 0.0 | |
36.7M | 27.6M | 13.6M | 15.7M | 10.4M | 8.9M | 100.3K | 129M | |
233.2M | 237.6M | 142.7M | 183.6M | 198.3M | 77.5M | 100.3K | 135.2M | |
541M | 580.7M | 570.7M | 808.6M | 950.8M | 267.3M | 100.3K | 210.6M | |
LIABILITIES | ||||||||
CURRENT LIABILITIES | ||||||||
153.3M | 191M | 174.3M | 324.1M | 206.8M | 134.6M | 17.6K | 0.0 | |
153.3M | 34.6M | 37.2M | 32.4M | 28.1M | 30.7M | 0.0 | 0.0 | |
0.0 | 156.4M | 137.1M | 291.7M | 178.7M | 104M | 17.6K | 0.0 | |
0.0 | 0.0 | 21M | 24M | 15.1M | 4M | 100.3K | 6M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.8M | 0.0 | 0.0 | |
0.0 | 0.0 | 1.7M | 1.8M | 3.1M | 4.8M | 0.0 | 0.0 | |
0.0 | 0.0 | 3.1M | 0.0 | 138.6M | 102.4M | 0.0 | 0.0 | |
55.6M | 22.6M | 61.1M | 81.6M | 9M | -102.4M | 0.0 | 0.0 | |
208.8M | 213.5M | 261.1M | 431.5M | 372.6M | 164.2M | 118K | 6M | |
NON-CURRENT LIABILITIES | ||||||||
0.0 | 0.0 | 0.0 | 0.0 | 19.9M | 106.4M | 0.0 | 49.3M | |
23.5M | 26.1M | 20.2M | 16.2M | 14.1M | 603.5M | 0.0 | 210.1M | |
23.5M | 26.1M | 23.2M | 20.2M | 38.9M | 716.2M | 0.0 | 259.4M | |
0.0 | 0.0 | 4.7M | 5.9M | 7.9M | 11.1M | 0.0 | 0.0 | |
232.3M | 239.6M | 284.3M | 451.7M | 411.5M | 880.4M | 118K | 265.4M | |
SHAREHOLDERS' EQUITY | ||||||||
-86.2M | -31M | -12.7M | -6.5M | -147K | 0.0 | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 447.7M | |
52K | 50K | 49K | 46K | 46K | 9K | 0.0 | 4K | |
2.7B | 2.6B | 2.5B | 2.3B | 2.2B | 411.9M | 0.0 | 25.3M | |
-2.3B | -2.2B | -2.2B | -1.9B | -1.6B | -1B | -17.6K | -527.9M | |
528K | -1.6M | -2.4M | -9.4M | -1.9M | 10K | 0.0 | 0.0 | |
308.7M | 341.1M | 286.4M | 356.9M | 535.4M | -617.1M | -17.6K | -54.8M | |
308.7M | 341.1M | 286.4M | 356.9M | 539.3M | -613.2M | -17.6K | -54.8M | |
0.0 | 0.0 | 0.0 | 0.0 | 3.9M | 3.9M | 0.0 | 0.0 | |
SUMMARY | ||||||||
541M | 580.7M | 570.7M | 808.6M | 950.8M | 267.3M | 100.3K | 210.6M | |
204.1M | 228.7M | 240.8M | 369.1M | 491.2M | 58.8M | 0.0 | 0.0 | |
0.0 | 0.0 | 4.7M | 5.9M | 27.8M | 138.4M | 0.0 | 49.3M | |
-78.3M | -194.5M | -111.7M | -97.9M | -272.1M | 46M | 0.0 | -26.2M | |
516,132,315 | 516,132,315 | 516,132,315 | 516,132,315 | 516,132,315 | 516,132,315 | 516,132,315 | 516,132,315 |
SEC Filings
CLOV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 18, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 30, 2026 | 2026 | |
8-K/A 8-K/A 2026 (Amended) N/A | March 06, 2026 | March 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 06, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 14, 2026 | January 14, 2026 | 2026 |
Related Guides
Continue your CLOV research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.